HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


L’Oréal earnings

This article was originally published in The Rose Sheet

Executive Summary

First half operating profit grew 7.8% to $1.37 bil. (€1=$1.22) on a strategy of cost control and like-for-like sales growth, firm reports Sept. 1. Adjusted operating profit was $1.4 bil., up 1%, and net income rose 21.8% to $1.2 bil. Cosmetics adjusted operating profit was $1.36 bil., while Dermatology contributed a $11.8 mil., L'Oréal adds. Company reported consolidated sales of $917 bil., up 6.4% like-for-like, or 3.6% on a reported basis, in July (1"The Rose Sheet" July 12, 2004, In Brief). Separately, the firm recently opened the first Lancôme concept store carrying the brand's makeup, skin care and fragrances in Hong Kong. Company plans to open 10 new stores this year in Asia and the U.S. and will open the renovated Lancôme Institute in Paris...

You may also be interested in...

L’Oréal results

L'Oréal True Match foundation and Garnier Fructis hair care helped drive Consumer Products sales up 5.1% like-for-like, or 2.2% on a reported basis, to $5 bil. (€1=$1.24) in the first half of 2004, French beauty company reports June 8. Luxury Products revenue rose 6.9% like-for-like, or 4% on a reported basis, to $2.03 bil., benefiting from sales of Lancôme Color ID makeup and Hypnôse mascara, firm adds. In North America, sales were up 6.2% like-for-like, but declined 2.7% on a reported basis to $2.26 bil. Western European revenues, impacted by "sluggish" consumer spending in France, Germany and Italy, were up 1.7% like-for-like, or 1.8% reported, to $4.84 bil. Consolidated sales were up 6.4% like-for-like, or 3.6% on a reported basis, to $9.17 bil...

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts